Immunisation coverage of children in the child welfare system: a systematic review protocol

Jennifer S Hermann1, Robin M Featherstone2,3, Margaret L Russell4

  • 1Faculty of Nursing, University of Alberta, Edmonton, Canada.

BMJ Open
|April 29, 2017
PubMed

Insights

Child welfare system involvement can disrupt routine childhood immunizations. This review examines vaccine coverage and barriers for these vulnerable children to improve public health outcomes.

Area of Science:

  • Public Health
  • Pediatrics
  • Health Services Research

Background:

  • Children in the child welfare system face unique challenges impacting their healthcare access.
  • Transitions in care and living arrangements can lead to missed preventive health services, including immunizations.

Purpose of the Study:

  • To systematically review and identify issues with childhood immunization coverage among children in the child welfare system.
  • To determine barriers and supports influencing vaccine uptake in this population.

Main Methods:

  • A comprehensive systematic literature review of published and unpublished studies from 2000 to present.
  • Searches across multiple databases (Medline, Embase, CINAHL, etc.) and grey literature, focusing on children aged 0-17 in high-income countries.
  • Narrative analysis of key findings regarding immunization coverage, comparisons, and influencing factors.

Main Results:

  • This section is to be populated upon completion of the systematic review.
  • Expected to detail current immunization coverage rates and identify specific barriers and facilitators.

Conclusions:

  • This systematic review will provide critical insights into the immunization status of children in the child welfare system.
  • Findings will inform targeted interventions to improve vaccine equity and child health outcomes.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
457
Vaccinations01:51

Vaccinations

Overview
52.8K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
446
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
340